Dimethyl fumarate Mylan Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Fingolimod Viatris 0,5 mg Capsule rigide Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

fingolimod viatris 0,5 mg capsule rigide

viatris pharma gmbh - fingolimodum - capsule rigide - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, calcii hydrogenophosphas dihydricus, glycinum, silica colloidalis anhydrica, magnesii stearas, kapselhülle: e 171, gelatina, e 172 (rubrum), e 172 (flavum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula. - multiple sklerose - synthetika

Dimethyl fumarate Teva Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Unione Europea - italiano - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

DIMETILFUMARATO PIRAMAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

dimetilfumarato piramal

piramal critical care italia s.p.a. - dimethyl fumarate - dimethyl fumarate

MUSTEF Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

mustef

adalvo limited - dimethyl fumarate - dimethyl fumarate

Sandimmun Infusionskonzentrat Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandimmun infusionskonzentrat

novartis pharma schweiz ag - ciclosporinum - infusionskonzentrat - ciclosporinum 50 mg, macrogol 36 glyceroli ricinioleas 650 mg, ethanolum 261 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - immunsuppressivum - biotechnologika

Odomzo 200 mg Capsule rigide Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

odomzo 200 mg capsule rigide

sun pharma switzerland ltd - sonidegibum - capsule rigide - sonidegibum 200 mg ut sonidegibi diphosphas, crospovidonum, lactosum monohydricum 38.60 mg, poloxamerum 188, natrii laurilsulfas corresp. natrium 0.605 mg, magnesii stearas, silica colloidalis anhydrica, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum q.s., pro capsula. - carcinoma a cellule basali - synthetika